(Q57134756)

English

Breast cancer chemoprevention

No description defined

In more languages

edit

Statements

instance of

scholarly article

0 references

title

Breast cancer chemoprevention (English)

0 references

author name string

Emmanuel M Gabriel

series ordinal

1

0 references

Ismail Jatoi

series ordinal

2

0 references

language of work or name

English

0 references

publication date

February 2012

0 references

published in

Expert Review of Anticancer Therapy

0 references

volume

12

0 references

issue

2

0 references

page(s)

223-8

0 references

cites work

Breast cancer chemoprevention: progress and controversy

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1586%2FERA.11.206

retrieved

21 January 2018

Overview of the main outcomes in breast-cancer prevention trials

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1586%2FERA.11.206

retrieved

21 January 2018

Preventive therapy for breast cancer: a consensus statement

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1586%2FERA.11.206

retrieved

21 January 2018

Tamoxifen for prevention of breast cancer: report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1586%2FERA.11.206

retrieved

21 January 2018

Italian randomized trial among women with hysterectomy: tamoxifen and hormone-dependent breast cancer in high-risk women

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1586%2FERA.11.206

retrieved

21 January 2018

Benefit/risk assessment for breast cancer chemoprevention with raloxifene or tamoxifen for women age 50 years or older

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1586%2FERA.11.206

retrieved

21 January 2018

Tamoxifen for the prevention of breast cancer: current status of the National Surgical Adjuvant Breast and Bowel Project P-1 study

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1586%2FERA.11.206

retrieved

21 January 2018

First results from the International Breast Cancer Intervention Study (IBIS-I): a randomised prevention trial

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1586%2FERA.11.206

retrieved

21 January 2018

Long-term results of tamoxifen prophylaxis for breast cancer--96-month follow-up of the randomized IBIS-I trial

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1586%2FERA.11.206

retrieved

21 January 2018

Continuing outcomes relevant to Evista: breast cancer incidence in postmenopausal osteoporotic women in a randomized trial of raloxifene

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1586%2FERA.11.206

retrieved

21 January 2018

The Effect of Raloxifene on Risk of Breast Cancer in Postmenopausal Women

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1586%2FERA.11.206

retrieved

21 January 2018

Effects of tamoxifen vs raloxifene on the risk of developing invasive breast cancer and other disease outcomes: the NSABP Study of Tamoxifen and Raloxifene (STAR) P-2 trial

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1586%2FERA.11.206

retrieved

21 January 2018

Update of the National Surgical Adjuvant Breast and Bowel Project Study of Tamoxifen and Raloxifene (STAR) P-2 Trial: Preventing breast cancer

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1586%2FERA.11.206

retrieved

21 January 2018

Exemestane for breast-cancer prevention in postmenopausal women.

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1586%2FERA.11.206

retrieved

21 January 2018

A comparison of letrozole and tamoxifen in postmenopausal women with early breast cancer

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1586%2FERA.11.206

retrieved

21 January 2018

Tamoxifen and breast cancer incidence among women with inherited mutations in BRCA1 and BRCA2: National Surgical Adjuvant Breast and Bowel Project (NSABP-P1) Breast Cancer Prevention Trial.

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1586%2FERA.11.206

retrieved

21 January 2018

Tamoxifen and risk of contralateral breast cancer in BRCA1 and BRCA2 mutation carriers: a case-control study. Hereditary Breast Cancer Clinical Study Group

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1586%2FERA.11.206

retrieved

21 January 2018

Risks, benefits, and effects on quality of life of selective estrogen-receptor modulator therapy in postmenopausal women at increased risk of breast cancer

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1586%2FERA.11.206

retrieved

21 January 2018

Prospective study of serum vitamin D and cancer mortality in the United States

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1586%2FERA.11.206

retrieved

21 January 2018

Identifiers

DOI

10.1586/ERA.11.206

0 references

PubMed publication ID

22316370

0 references

(Q57134756)

Breast cancer chemoprevention

Statements

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)